📖
Neurotransmitter-Defined Degeneration Patterns in Sporadic and C9orf72-Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems-Implications for Therapy Development.
Tahedl M, Siah WF, Lope J, Hengeveld JC, Doherty MA, McLaughlin RL, Hardiman O, Tan EL, Toomey A, Kleinerova J, Bede P

Neurotransmitter-Defined Degeneration Patterns in Sporadic and C9orf72-Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems-Implications for Therapy Development.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Ann Neurol.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Neurotransmitter-Defined Degeneration Patterns in Sporadic and C9orf72-Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems-Implications for Therapy Development.
Author / Organization Tahedl M, Siah WF, Lope J, Hengeveld JC, Doherty MA, McLaughlin RL, Hardiman O, Tan EL, Toomey A, Kleinerova J, Bede P
Subject & Discipline Ann Neurol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-71310
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »